Ductal carcinoma in situ: Size and resection volume predict margin status

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 33, Issue 5, 2010, Pages 438-442

  Melstrom, Laleh G ^a   Melstrom, Kurt A ^b   Wang, Edward C ^a   Pilewskie, Melissa ^a   Winchester, David J ^c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^c NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

Author keywords

DCIS; Lumpectomy volume; Margin status; Resection volume; Tumor size

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGE DISTRIBUTION; ARTICLE; CANCER GRADING; CANCER SIZE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; PARTIAL MASTECTOMY; POSITIVE SURGICAL MARGIN; RETROSPECTIVE STUDY; TREATMENT OUTCOME; FEMALE; MIDDLE AGED; MINIMAL RESIDUAL DISEASE; MULTIVARIATE ANALYSIS; PATHOLOGY; RISK FACTOR; SEGMENTAL MASTECTOMY; STATISTICAL MODEL; TUMOR RECURRENCE;

CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; HUMANS; LOGISTIC MODELS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 78049437571     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e3181b9cf31     Document Type: Article

References (36)

1. Fisher B, Costantino J, Redmond C, et al. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med. 1993;328:1581-1586.
2. Fisher B, Redmond C, Poisson R, et al. Eight-year results of randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med. 1989;320:822-823.
3. Veronesi U, Luini A, Del Vecchio M, et al. Radiotherapy after breastpreserving surgery in women with localized cancer of the breast. N Engl J Med. 1993;328:1587-1591.
4. Fisher B, Dignam J, Wolmark N, et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol. 1998;16:441-452.
5. Julien JP, Bijker N, Fentiman IS, et al. Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomized phase III trial 10853. EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. Lancet. 2000;355:528-533.
6. Silverstein MJ, Lagios M, Groshen S, et al. The influence of margin width on local control of ductal carcinoma in situ of the breast. N Engl J Med. 1999;340:1455-1461.
7. Miller AR, Brandao G, Prihoda TJ, et al. Positive margins following surgical resection of breast carcinoma: analysis of pathologic correlates. J Surg Oncol. 2004;86:134-140.
8. Guidi AJ, Connolly JL, Harris JR, et al. The relationship between shaved margin and inked margin status in breast excision specimens. Cancer. 1997;79:1568-1573.
9. England DW, Chan SY, Stonelake PS, et al. Assessment of excision margins following wide local excision for breast carcinoma using specimen scrape cytology and tumour bed biopsy. Eur J Surg Oncol. 1994;20:425-429.
10. Mokbel K, Ahmed M, Nash A, et al. Reexcision operations in nonpalpable breast cancer. J Surg Oncol. 1995;58:225-228.
11. Renton SC, Gazet JC, Ford HT, et al. The importance of the resection margin in conservative surgery for breast cancer. Eur J Surg Oncol. 1996;22:17-22.
12. Macmillan RD, Purushotham AD, Mallon E, et al. Tumor bed positivity predicts outcome after breast-conserving surgery. Br J Surg. 1997;84:1559-1562.
13. Harris EE, Schultz DJ, Jones HA, et al. Factors associated with residual disease on re-excision in patients with ductal carcinoma in situ of the breast. Cancer J. 2003;9:42-48.
14. Silverstein MJ, Lagios MD, Martino S, et al. Outcome after invasive local recurrence in patients with ductal carcinoma in situ of the breast. J Clin Oncol. 1998;16:1367-1373.
15. Dunne C, Burke JP, Morrow M, et al. Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ. J Clin Oncol. 2009;27:1615-1620.
16. Olivotto I, Levine M. Clinical practice guidelines for the care and treatment of breast cancer: the management of ductal carcinoma in situ. CMAJ. 2001;165:912-913. (Pubitemid 34028232)
17. Morrow M, Strom EA, Bassett LW, et al. Standard for the management of ductal carcinoma in situ of the breast (DCIS). CA Cancer J Clin. 2002;52: 256-276. (Pubitemid 35345498)
18. Schwartz GL, Solin LJ, Olivotto IO, et al. Consensus conference on the treatment of in situ ductal carcinoma of the breast, April 22-25, 1999. Cancer. 2000;88:946-954.
19. Fisher B, Dignam J, Wolmark N, et al. Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial. Lancet. 1999;353:1993-2000. (Pubitemid 29271743)
20. Houghton J, George WD, Cuzick J, et al. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand. Lancet. 2003;362:95-102. (Pubitemid 36831018)
21. Baxter NN, Virnig BA, Durham SB, et al. Trends in the treatment of ductal carcinoma in situ of the breast. J Natl Cancer Inst. 2004;96:443-448.
22. Bijker N, Peterse JL, Duchateau L, et al. Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853. J Clin Oncol. 2001;19:2263-2271.
23. Fisher ER, Costantino J, Fisher B, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) protocol B-17: intraductal carcinoma (ductal carcinoma in situ). The National Surgical Adjuvant Breast and Bowel Project collaborating investigators. Cancer. 1995;75:1310-1319.
24. Silverstein MJ, Lagios MD, Craig PH, et al. A prognostic index for ductal carcinoma in situ of the breast. Cancer. 1996;77:2267-2274.
25. Van Zee KJ, Liberman L, Samli B, et al. Long term follow-up of women with ductal carcinoma in situ treated with breast-conserving surgery: the effects of age. Cancer. 1999;86:1757-1767.
26. Macdonald HR, Silverstein MJ, Lee LA, et al. Margin width as the sole determinant of local recurrence after breast conservation in patients with ductal carcinoma in situ of the breast. Am J Surg. 2006;192:420-422.
27. Vicini FA, Kestin LL, Goldstein NS, et al. Relationship between excision volume, margin status, and tumor size with the development of local recurrence in patients with ductal carcinoma-in-situ treated with breast-conserving therapy. J Surg Oncol. 2001;76:245-254.
28. Sahoo S, Recant WM, Jaskowiak N, et al. Defining negative margins in DCIS patients treated with breast conservation therapy: The University of Chicago experience. Breast J. 2005;11:242-247.
29. Neuschatz AC, DiPetrillo T, Steinhoff M, et al. The value of breast lumpectomy margin assessment as a predictor of residual tumor burden in ductal carcinoma in situ of the breast. Cancer. 2002;94:1917-1924.
30. Ratanawichitrasin A, Rybicki LA, Steiger E, et al. Predicting the likelihood of residual disease in women treated for ductal carcinoma in situ. J Am Coll Surg. 1999;188:17-21.
31. Cheng L, Al-Kasai NK, Gordon NH, et al. Relationship between the size and margin status of ductal carcinoma in situ of the breast and residual disease. J Natl Cancer Inst. 1997;89:1356-1360.
32. Dillon MF, McDermott EW, O'Doherty A, et al. Factors affecting successful breast conservation for ductal carcinoma in situ. Ann Surg Oncol. 2007;14: 1618-1628.
33. Cellini C, Hollenbeck ST, Christos P, et al. Factors associated with residual breast cancer after re-excision for close or positive margins. Ann Surg Oncol. 2004;11:915-920.
34. Luu H, Otis C, Reed WP, et al. The unsatisfactory margin in breast cancer surgery. Am J Surg. 1999;178:362-366.
35. Tartter PI, Bleiweiss IJ, Levchenko S. Factors associated with clear biopsy margins and clear reexcision margins in breast cancer specimens from candidates for breast conservation. J Am Coll Surg. 1997;185:268-273.
36. Sigal-Zafrani B, Lewis JS, Clough KB, et al. Histological margin assessment for breast ductal carcinoma in situ: precision and implications. Mod Pathol. 2004;17:81-88. (Pubitemid 41656456)